Baptista Filipa I, Pinto Maria J, Elvas Filipe, Martins Tiago, Almeida Ramiro D, Ambrósio António F
Centre of Ophthalmology and Vision Sciences, IBILI, Faculty of Medicine, University of Coimbra, 3004-548 Coimbra, Portugal; Pharmacology and Experimental Therapeutics, IBILI, Faculty of Medicine, University of Coimbra, 3004-548 Coimbra, Portugal.
CNC-Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal; PhD Programme in Experimental Biology and Biomedicine (PDBEB), Center for Neuroscience and Cell Biology, University of Coimbra, 3004-517 Coimbra, Portugal.
Exp Eye Res. 2014 Oct;127:91-103. doi: 10.1016/j.exer.2014.07.011. Epub 2014 Jul 24.
Diabetic retinopathy is a leading cause of vision loss and blindness. Disruption of axonal transport is associated with many neurodegenerative diseases and might also play a role in diabetes-associated disorders affecting nervous system. We investigated the impact of type 1 diabetes (2 and 8 weeks duration) on KIF1A, KIF5B and dynein motor proteins in the retina. Additionally, since hyperglycemia is considered the main trigger of diabetic complications, we investigated whether prolonged exposure to elevated glucose could affect the content and distribution of motor proteins in retinal cultures. The immunoreactivity of motor proteins was evaluated by immunohistochemistry in retinal sections and by immunoblotting in total retinal extracts from streptozotocin-induced diabetic and age-matched control animals. Primary retinal cultures were exposed to high glucose (30 mM) or mannitol (osmotic control; 24.5 mM plus 5.5 mM glucose), for seven days. Diabetes decreased the content of KIF1A at 8 weeks of diabetes as well as KIF1A immunoreactivity in the majority of retinal layers, except for the photoreceptor and outer nuclear layer. Changes in KIF5B immunoreactivity were also detected by immunohistochemistry in the retina at 8 weeks of diabetes, being increased at the photoreceptor and outer nuclear layer, and decreased in the ganglion cell layer. Regarding dynein immunoreactivity there was an increase in the ganglion cell layer after 8 weeks of diabetes. No changes were detected in retinal cultures. These alterations suggest that axonal transport may be impaired under diabetes, which might contribute to early signs of neural dysfunction in the retina of diabetic patients and animal models.
糖尿病性视网膜病变是视力丧失和失明的主要原因。轴突运输的破坏与许多神经退行性疾病有关,也可能在影响神经系统的糖尿病相关疾病中起作用。我们研究了1型糖尿病(病程2周和8周)对视网膜中驱动蛋白1A(KIF1A)、驱动蛋白5B(KIF5B)和动力蛋白的影响。此外,由于高血糖被认为是糖尿病并发症的主要触发因素,我们研究了长时间暴露于高糖环境是否会影响视网膜培养物中驱动蛋白的含量和分布。通过免疫组化在视网膜切片中以及通过免疫印迹在链脲佐菌素诱导的糖尿病动物和年龄匹配的对照动物的全视网膜提取物中评估驱动蛋白的免疫反应性。将原代视网膜培养物暴露于高糖(30 mM)或甘露醇(渗透对照;24.5 mM加5.5 mM葡萄糖)中7天。糖尿病在病程8周时降低了KIF1A的含量以及大多数视网膜层中KIF1A的免疫反应性,但光感受器和外核层除外。免疫组化还检测到糖尿病病程8周时视网膜中KIF5B免疫反应性的变化,在光感受器和外核层增加,在神经节细胞层减少。关于动力蛋白的免疫反应性,糖尿病病程8周后神经节细胞层增加。在视网膜培养物中未检测到变化。这些改变表明糖尿病状态下轴突运输可能受损,这可能导致糖尿病患者和动物模型视网膜神经功能障碍的早期迹象。